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Background:  The management of hypertrophic cardiomyopathy (HCM) is directed by the presence and magnitude of left ventricular outflow tract 
(LVOT) obstruction, which frequently is dynamic. We examined the extent and clinical impact of variability of the LVOT gradient during an individual 
hemodynamic study.
Methods:  Fifty symptomatic patients with HCM (mean age, 55±15 years; 48% male) underwent cardiac catheterization with high-fidelity, 
micromanometer-tip catheters including transseptal measurement of left-sided pressures. All measures were obtained at baseline, preceding any 
drug administration or interventions. Obstruction was defined as a resting LVOT gradient greater than or equal to 30 mmHg. Variability in LVOT 
gradient was calculated as the difference between the peak and smallest LVOT gradients.
Results:  The average peak LVOT gradient was 54.6±56.4 mmHg; however, average within study variability of the LVOT gradient was 49.0±53.1 
mmHg (range 0-210.8 mmHg). Due to this variability, discrepant classification of resting LVOT obstruction was possible in 25 patients, or 50% of the 
population (identified as shaded circles in Figure).
Conclusions:  In symptomatic patients with HCM, the LVOT gradient fluctuates significantly, even during individual studies of hemodynamic 
assessment. Spontaneous variability can lead to misclassification of obstruction severity, which has significant implications for the management of 
patients with HCM.
